BridgeMD
New treatment option for Cardiogenic Shock
Official title The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
ClinicalTrials.gov ID: NCT07062744
What this study is testing
- What it's testing
- This clinical trial examines whether the use of the Swan-Ganz catheter, a specialized pulmonary artery catheter, can improve hemodynamic management and treatment outcomes in patients experiencing cardiogenic shock due to acute myocardial infarction (AMI). Cardiogenic shock is a critical condition marked by the heart's inability to supply adequate blood to the organs, often resulting from a severe heart attack.
- Time commitment: about 3 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years.
- Provided written informed consent to participate in the study.
- Diagnosed with cardiogenic shock due to acute myocardial infarction according to IABP-SHOCK II (2012) criteria:
- Systolic blood pressure (SBP) \ 90 mmHg.
- Evidence of end-organ hypoperfusion, indicated by at least one of the following: Altered mental status, Urine output \ 2 mmol/L.
You likely can't join if
- Presence of cervical cellulitis.
- Inability to identify neck anatomy or history of cervical radiotherapy.
- Coagulopathy (INR \> 1.5 and/or platelet count \< 50 G/L).
- End-stage chronic diseases, including: Advanced malignancy, advanced-stage HIV, bedridden patients for more than 3 months, decompensated liver...
- Patients with cardiac arrest or mechanical complications such as myocardial rupture prior to Swan-Ganz catheterization.
- Congenital heart defects or intracardiac shunts. Refusal of participation by the patient or their legal representative.
The study team makes the final eligibility decision.
Where it's taking place
- Hanoi, Vietnam
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hanoi, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.